
Materials · Fertilizers & Agricultural Chemicals
$78.61
+1.60%
Vol: 5.3M
Friday, June 19, 2026
No material news in the last 48 hours.
No material news in the last 48 hours.
No material news in the last 48 hours.
In mid-June 2026, Corteva attracted a cluster of analyst actions: Barclays' Benjamin Theurer raised his target to $91 from $84 (Overweight) and Morgan Stanley's Vincent Andrews lifted his to $95 from $84 (Overweight), while UBS's Joshua Spector trimmed his to $86 from $90 (Neutral). The renewed attention comes alongside Corteva's $0.18 quarterly dividend payable June 15, 2026, and its progress toward splitting into two companies in Q4 2026 — a crop-protection business ("New Corteva," headquartered in Indianapolis) and a seed and genetics business ("Vylor," headquartered in Johnston, Iowa). Q1 2026 net sales were $4.9 billion, up 11% year-over-year, supporting the bullish case built on product development, pricing discipline, and the separation unlocking value. The bear case, reflected in the UBS cut, centers on rising input costs, trade-related uncertainty, and execution risk on the complex separation. Q2 2026 earnings are due July 30.
No material news in the last 48 hours.
No material news in the last 48 hours.
On May 12, 2026, Corteva announced that 'New Corteva' (crop protection) will be headquartered in Indianapolis, Indiana, while its seed and genetics spinoff Vylor will be based in Johnston, Iowa. The separation remains on track for Q4 2026. Q1 2026 results posted May 5 showed 11% net sales growth, 7% organic growth, 21% EBITDA growth, and EPS of $1.50 versus $1.17 consensus. CEO Chuck Magro told the BMO Farm to Market conference on May 14 there were 'no showstoppers' for the spin. UBS raised PT to $90 (Neutral) and Citi raised PT to $85 (Neutral).
No material news in the last 48 hours.
Corteva announced May 12 that 'New Corteva' (crop protection) will be HQ'd in Indianapolis and the spinoff branded Vylor (advanced seed and genetics) will be HQ'd in Johnston, Iowa, with the separation targeted for Q4 2026. Q1 2026 net sales rose 11% YoY (+7% organic) and EPS of $1.50 beat $1.174 consensus; FY26 outlook reaffirmed. CEO Magro and CFO Johnson presented at the BMO Farm to Market conference May 14. Capital World disclosed a 5.5% stake (May 13). Risk: pricing pressure in ag markets and execution risk on the spin.
On May 12, 2026, Corteva announced headquarters for the two future companies after its planned Q4 2026 separation: "New Corteva" (crop protection) in Indianapolis, Indiana, and Vylor (advanced seed and genetics) in Johnston, Iowa. On May 14, CEO Chuck Magro and CFO David Johnson presented at the BMO Global Farm to Market Conference. These follow strong Q1 2026 results (net sales +11%, organic sales +7%, Operating EBITDA $1.44B, Operating EPS $1.50) and reaffirmed FY26 guidance ($4.0-$4.2B EBITDA, $3.45-$3.70 EPS). Analyst targets were raised: RBC to $95, Oppenheimer to $89, Wells Fargo to $90; consensus 12-month target lifted to $89.6 (16 Buys, 9 Holds).
CEO Chuck Magro and CFO David Johnson presented at the BMO Global Farm to Market conference on May 14, 2026. The company reaffirmed full-year 2026 guidance with Operating EBITDA of $4.0-4.2 billion and Operating EPS of $3.45-3.70. Corteva is on track for a Q4 2026 corporate separation: the crop protection company (New Corteva) will be headquartered in Indianapolis, Indiana, while the seed and genetics spinoff (Vylor) will be based in Johnston, Iowa. Q1 2026 net sales rose 11% to $4.9 billion with organic sales up 7% and operating EBITDA up 21%. Recent analyst price target increases include UBS ($90), Bank of America ($90), and Citi ($85). Sentiment is positive given strong execution and clarifying separation milestones.
Corteva announced its advanced seed and genetics SpinCo will be branded Vylor, Inc., headquartered in Johnston, Iowa, while New Corteva (crop protection) will be headquartered in Indianapolis, Indiana. The separation remains on track for Q4 2026. Vylor will be anchored by more than 4,000 germplasm patents and more than 2,000 biotechnology patents, with a pipeline including proprietary hybrid wheat, gene editing, multi-disease resistance corn, and next-generation biofuels. Q1 2026 sales rose 11% YoY with organic sales up 7% and operating EPS of $1.50 beating $1.18 consensus by 27%. The company reaffirmed FY2026 guidance of $4.0-$4.2B operating EBITDA and operating EPS of $3.45-$3.70. CEO Chuck Magro and CFO David Johnson are speaking at the BMO Global Farm to Market conference today (May 14) at 11:00 a.m. EDT. CTVA declared a $0.18 dividend with ex-date June 1. BofA recently raised its price target. Analyst consensus is Buy with average PT of $84.13.
On May 12, 2026, Corteva announced that 'New Corteva,' its future crop protection company, will be headquartered in Indianapolis, Indiana, while Vylor, its advanced seed and genetics spinoff, will be headquartered in Johnston, Iowa. New Corteva's Global Corporate Business Center will be in Wilmington, Delaware, and Vylor's in Southeast Pennsylvania. This follows the planned separation in Q4 2026. Corteva also previously announced Luke Kissam as New Corteva CEO. The company recently reaffirmed full-year 2026 guidance with operating EBITDA of $4.0-$4.2 billion. Analyst price targets have been raised by UBS, BofA, and Citi following strong Q1 results.
Corteva announced on May 4, 2026 that its planned seed-and-genetics spinoff will be branded Vylor, Inc., with the separation on track for Q4 2026; Vylor carries 4,000+ germplasm patents and 2,000+ biotech patents. Q1 2026 net sales rose 11% YoY to $4.9B with operating EBITDA of $1.44B and EPS of $1.50, reaffirming full-year guidance of $4.0-$4.2B EBITDA and $3.45-$3.70 EPS. The company plans $500M in buybacks and declared a $0.18 quarterly dividend. Multiple analysts raised targets following the print: UBS to $90 from $88, Bank of America to $90 from $87, Citi to $85 from $83. CEO Chuck Magro and CFO David Johnson will present at BMO's Global Farm to Market conference on May 14.
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| CTVACORTEVA | $78.61 | +1.60% | -0.3% | 19.1x | 0.57 | $52.6B |
| CFCF | $103.01 | -2.68% | -16.5% | 9.0x | 0.38 | $15.8B |
| MOSMOSAIC | $22.88 | +1.62% | +4.8% | 12.5x | 0.81 | $7.3B |
| LINLINDE | $512.15 | -0.72% | +1.1% | 26.0x | 0.73 | $236.8B |
| NEMNEWMONT | $104.04 | -1.54% | -3.4% | 9.1x | 0.46 | $110.8B |
| FCXFREEPORT | $68.84 | -0.32% | +12.8% | 17.6x | 1.36 | $98.7B |
Price between 50d and 200d. Testing 50d support.